Journey Medical Corp (DERM)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $122.24M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 36.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 25.7, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about DERM
News
DERM Valuation
GNG's valuation label for DERM is Undervalued. It trades at 17.3x forward earnings.
- Forward P/E
- 17.3x
- EV/EBITDA
- 41.2x
- P/B
- 3.2x
DERM Profitability: Margins, ROIC and FCF
Journey Medical (DERM) has a gross margin of 65.9%, an operating margin of -2.9% and a net margin of -7.3%. It posts -2.8% ROIC and a -12.3% FCF margin.
- Gross margin
- 65.9%
- Operating margin
- -2.9%
- Net margin
- -7.3%
- ROIC
- -2.8%
- ROE
- -17.6%
- FCF margin
- -12.3%
Journey Medical Competitors
The companies most similar to Journey Medical (DERM) include Anika Therapeutics, Cardiol Therapeutics Inc Class A and Akebia Ther.
Sector: Healthcare
Companies most similar to Journey MedicalDERM Analyst Ratings
Journey Medical (DERM) has a Buy consensus from 4 analysts: 4 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 4
- Strong Buy
- 0
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
DERM Bull Case vs Bear Case
Bear case
- DERM has a -7.3% net profit margin.
- DERM beat EPS estimates in 37.5% of its last 8 reported quarters.
DERM Earnings: Beat Rate and Next Report
Journey Medical (DERM) beat the EPS estimate in 3 of the last 8 quarters (37.5%).
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -7.2%
- EPS estimate (fiscal period ending Dec 31, 2026)
- $0.00
DERM Earnings Call
The latest DERM earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptDERM ETF Holders
GNG tracks 3 ETFs that hold DERM. The largest weights:
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- iShares Russell 2000 ETF (IWM), <0.01% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), <0.01% of the fund
Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About DERM
Does DERM pay dividends?
Journey Medical Corp (DERM) does not currently pay a regular dividend.
What is DERM's market cap?
Journey Medical Corp (DERM) has a market capitalization of $122.24M with a current stock price of $3.70.
DERM pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.